ARTICLE | Clinical News
Ditropan XL beats Detrol in Phase IV study
April 10, 2001 7:00 AM UTC
Alza (AZA) reported that in a head-to-head U.S. Phase IV trial of its Ditropan XL oxybutynin versus Detrol tolterodine from Pharmacia (PHA), Ditropan XL reduced weekly urge incontinence, total inconti...